Fedenia Advisers’s AstraZeneca AZN Stock Holding History

Fedenia Advisers’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$36.2K	Buy	+191	New	+$35.9K	0.01%	255
2026 Q1	–	Sell	-3,915	Closed	-$720K	–	100
2025 Q4	$720K	Buy	3,915 +972	+33%	+$170K	0.28%	77
2025 Q3	$452K	Buy	2,943 +641	+28%	+$97K	0.18%	104
2025 Q2	$322K	Sell	2,302 -108	-4%	-$15.1K	0.15%	108
2025 Q1	$354K	Sell	2,410 -963	-29%	-$139K	0.23%	77
2024 Q4	$442K	Buy	+3,373	New	+$472K	0.26%	76

Other funds holding AZN

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

CDDEC

Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return

MIF

Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

ZIC

ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

Fedenia Advisers's AZN Position: Q2 2026 in Review

Fedenia Advisers opened a new position in AstraZeneca (AZN) in Q2 2026: 191 shares worth $36.2K. The stake represents 0.01% of the portfolio and ranks #255 among its holdings. This is a return to the name: Fedenia Advisers previously reported a position in AZN as recently as Q4 2025.

Fedenia Advisers first reported a position in AZN in Q4 2024 and has held it in 6 quarters since. The position peaked at $720K in Q4 2025. 443 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Fedenia Advisers held 191 shares of AstraZeneca worth $36.2K as of Q2 2026.
AstraZeneca was a new Fedenia Advisers position in Q2 2026.
AstraZeneca made up 0.01% of Fedenia Advisers's portfolio in Q2 2026, its #255 holding.
Fedenia Advisers first reported a position in AstraZeneca in Q4 2024 and has held it in 6 quarters since.
Fedenia Advisers's AstraZeneca position peaked at $720K in Q4 2025.
443 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Fedenia Advisers's 13F filing for Q2 2026, filed 22 Jul 2026.